155 related articles for article (PubMed ID: 15964124)
1. Multi-centre study of intraurethral valve-pump catheter in women with a hypocontractile or acontractile bladder.
Chen TY; Ponsot Y; Carmel M; Bouffard N; Kennelly MJ; Tu LM
Eur Urol; 2005 Oct; 48(4):628-33. PubMed ID: 15964124
[TBL] [Abstract][Full Text] [Related]
2. Types of urethral catheters for management of short-term voiding problems in hospitalized adults: a short version Cochrane review.
Schumm K; Lam TB
Neurourol Urodyn; 2008; 27(8):738-46. PubMed ID: 18951451
[TBL] [Abstract][Full Text] [Related]
3. Clean intermittent catheterization--physical and psychological complications.
Bakke A
Scand J Urol Nephrol Suppl; 1993; 150():1-69. PubMed ID: 8438132
[TBL] [Abstract][Full Text] [Related]
4. Intermittent catheterization with a prelubricated catheter in spinal cord injured patients: a prospective randomized crossover study.
Giannantoni A; Di Stasi SM; Scivoletto G; Virgili G; Dolci S; Porena M
J Urol; 2001 Jul; 166(1):130-3. PubMed ID: 11435839
[TBL] [Abstract][Full Text] [Related]
5. Long-term bladder drainage: Suprapubic catheter versus other methods: a scoping review.
Hunter KF; Bharmal A; Moore KN
Neurourol Urodyn; 2013 Sep; 32(7):944-51. PubMed ID: 23192860
[TBL] [Abstract][Full Text] [Related]
6. A prospective randomized trial of the LoFric hydrophilic coated catheter versus conventional plastic catheter for clean intermittent catheterization.
Vapnek JM; Maynard FM; Kim J
J Urol; 2003 Mar; 169(3):994-8. PubMed ID: 12576829
[TBL] [Abstract][Full Text] [Related]
7. Satisfaction with urethral injection of botulinum toxin A for detrusor sphincter dyssynergia in patients with spinal cord lesion.
Kuo HC
Neurourol Urodyn; 2008; 27(8):793-6. PubMed ID: 18508331
[TBL] [Abstract][Full Text] [Related]
8. [Usefulness of nocturnal urethral indwelling catheter for treating bladder dysfunction with nocturnal polyuria: case report of 3 women].
Numata A; Taniguchi N; Kitahara K; Yamaguchi S; Kaneko S; Yachiku S; Tamaki G; Watabe Y; Motoya T; Iuchi H
Hinyokika Kiyo; 2003 Jan; 49(1):33-7. PubMed ID: 12629779
[TBL] [Abstract][Full Text] [Related]
9. A new intraurethral sphincter prosthesis with a self contained urinary pump.
Nativ O; Moskowitz B; Issaq E; Condrea A; Kastin A; Halachmi S; Burbara J; Madjar S; Beyar M
ASAIO J; 1997; 43(3):197-203. PubMed ID: 9152491
[TBL] [Abstract][Full Text] [Related]
10. Nonsurgical transurethral collagen denaturation for stress urinary incontinence in women: 12-month results from a prospective long-term study.
Elser DM; Mitchell GK; Miklos JR; Nickell KG; Cline K; Winkler H; Wells WG
J Minim Invasive Gynecol; 2009; 16(1):56-62. PubMed ID: 19013110
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
12. Comparison of fesoterodine and tolterodine in patients with overactive bladder.
Chapple CR; Van Kerrebroeck PE; Jünemann KP; Wang JT; Brodsky M
BJU Int; 2008 Nov; 102(9):1128-32. PubMed ID: 18647298
[TBL] [Abstract][Full Text] [Related]
13. Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare Open-Label Trial (VOLT).
Garely AD; Kaufman JM; Sand PK; Smith N; Andoh M
Clin Ther; 2006 Nov; 28(11):1935-46. PubMed ID: 17213014
[TBL] [Abstract][Full Text] [Related]
14. Intermittent catheterisation with hydrophilic-coated catheters (SpeediCath) reduces the risk of clinical urinary tract infection in spinal cord injured patients: a prospective randomised parallel comparative trial.
De Ridder DJ; Everaert K; Fernández LG; Valero JV; Durán AB; Abrisqueta ML; Ventura MG; Sotillo AR
Eur Urol; 2005 Dec; 48(6):991-5. PubMed ID: 16137822
[TBL] [Abstract][Full Text] [Related]
15. Trans-obturator vaginal tape (TOT) for female stress incontinence: one year follow-up in 120 patients.
Roumeguère T; Quackels T; Bollens R; de Groote A; Zlotta A; Bossche MV; Schulman C
Eur Urol; 2005 Nov; 48(5):805-9. PubMed ID: 16182440
[TBL] [Abstract][Full Text] [Related]
16. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of oxybutynin transdermal system in spinal cord injury patients with neurogenic detrusor overactivity and incontinence: an open-label, dose-titration study.
Kennelly MJ; Lemack GE; Foote JE; Trop CS
Urology; 2009 Oct; 74(4):741-5. PubMed ID: 19628264
[TBL] [Abstract][Full Text] [Related]
18. Short term outcomes of high power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate.
Volkan T; Ihsan TA; Yilmaz O; Emin O; Selcuk S; Koray K; Bedi O
Eur Urol; 2005 Oct; 48(4):608-13. PubMed ID: 16135396
[TBL] [Abstract][Full Text] [Related]
19. Comparing clean intermittent catheterisation and transurethral indwelling catheterisation for incomplete voiding after vaginal prolapse surgery: a multicentre randomised trial.
Hakvoort RA; Thijs SD; Bouwmeester FW; Broekman AM; Ruhe IM; Vernooij MM; Burger MP; Emanuel MH; Roovers JP
BJOG; 2011 Aug; 118(9):1055-60. PubMed ID: 21481147
[TBL] [Abstract][Full Text] [Related]
20. The outcome of voiding dysfunction managed with clean intermittent catheterization in neurologically and anatomically normal children.
Pohl HG; Bauer SB; Borer JG; Diamond DA; Kelly MD; Grant R; Briscoe CJ; Doonan G; Retik AB
BJU Int; 2002 Jun; 89(9):923-7. PubMed ID: 12010241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
